These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pitavastatin: a new HMG-CoA reductase inhibitor. Wensel TM; Waldrop BA; Wensel B Ann Pharmacother; 2010 Mar; 44(3):507-14. PubMed ID: 20179258 [TBL] [Abstract][Full Text] [Related]
5. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice]. Olsson AG; Nilsson PM Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786 [No Abstract] [Full Text] [Related]
6. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
7. Drugs for lipids. Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395 [No Abstract] [Full Text] [Related]
8. Pitavastatin: an overview. Saito Y Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281 [TBL] [Abstract][Full Text] [Related]
9. Pitavastatin calcium: clinical review of a new antihyperlipidemic medication. Yee LL; Wright EA Clin Ther; 2011 Aug; 33(8):1023-42. PubMed ID: 21816477 [TBL] [Abstract][Full Text] [Related]
10. Should we clean up the reputation of "dirty drugs"? Pierce G Can J Physiol Pharmacol; 2012 Oct; 90(10):1333-4. PubMed ID: 23020177 [No Abstract] [Full Text] [Related]
12. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259 [TBL] [Abstract][Full Text] [Related]
13. Searching the place of pitavastatin in the current treatment of patients with dyslipidemia. Barrios V; Escobar C; Zamorano JL Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1597-612. PubMed ID: 24215190 [TBL] [Abstract][Full Text] [Related]
14. New evidence on pitavastatin: efficacy and safety in clinical studies. Teramoto T; Shimano H; Yokote K; Urashima M Expert Opin Pharmacother; 2010 Apr; 11(5):817-28. PubMed ID: 20201733 [TBL] [Abstract][Full Text] [Related]